Article Details

Sumitomo Pharma Oncology Presents Preliminary Data from Phase 1/2 Clinical Study ...

Retrieved on: 2022-12-10 23:13:53

Tags for this article:

Click the tags to see associated articles and topics

Sumitomo Pharma Oncology Presents Preliminary Data from Phase 1/2 Clinical Study .... View article details on hiswai:

Excerpt

The dose escalation portion of the study has enrolled 9 patients at the time of the analysis. To date, five dose levels of TP-3654 were evaluated, ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up